Continuous glucose monitoring adherence significantly lowers emergency and inpatient visits for diabetes-related complications in people with type 2 diabetes on intensive insulin therapy. The authors...
A new optical device using visible light photoplethysmography accurately measured blood glucose in patients with diabetes, achieving a MARD of 8.8% and 100% clinical agreement in the Consensus Error Grid....
A retrospective cohort study presented at the American Diabetes Association found that combining continuous glucose monitoring (CGM) with GLP-1 agonist therapy led to significantly greater reductions in...
A real-world study of a fasting mimicking diet program showed improved glycemic control, medication reduction, and weight loss in people with type 2 diabetes, with high engagement and satisfaction rates....
A post hoc analysis of the SURMOUNT-1 trial reveals that cardiometabolic improvements achieved after 176 weeks of tirzepatide may diminish significantly within 17 weeks of treatment cessation, particularly...
In this Roundtable Wrap-Up, we offer an abbreviated version of the roundtable discussion on the multidisciplinary approach to managing patients with diabetes and the value of utilizing the services of a...
In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.
Researchers investigated semaglutide’s impact on weight-related muscle loss and its potential impact on spinal surgical outcomes, specifically transforaminal lumbar interbody fusion.
In this COVID-19 roundup, the CDC reports a record low number of COVID-19 hospitalizations, metformin reduces the likelihood of SARS-CoV-2 Viral load and rebound, remdesivir reduces mortality in older...
A team of researchers sought to establish the association between patients with diabetic retinopathy and quality of life, including vision-related quality of life.
